
Lakshmi Sarada Channavajjala
Examiner (ID: 456, Phone: (571)272-0591 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1615, 1611 |
| Total Applications | 1737 |
| Issued Applications | 722 |
| Pending Applications | 210 |
| Abandoned Applications | 818 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7027837
[patent_doc_number] => 20010014344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-16
[patent_title] => 'Cosmetic composition including nonionic guar gum and noncrosslinked anionic polymer'
[patent_app_type] => new
[patent_app_number] => 09/799601
[patent_app_country] => US
[patent_app_date] => 2001-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3216
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20010014344.pdf
[firstpage_image] =>[orig_patent_app_number] => 09799601
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/799601 | Cosmetic composition including nonionic guar gum and noncrosslinked anionic polymer | Mar 6, 2001 | Abandoned |
Array
(
[id] => 7065630
[patent_doc_number] => 20010044473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-22
[patent_title] => 'S(+) desmethylselegiline and its use in transdermal delivery compositions'
[patent_app_type] => new
[patent_app_number] => 09/800040
[patent_app_country] => US
[patent_app_date] => 2001-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12859
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20010044473.pdf
[firstpage_image] =>[orig_patent_app_number] => 09800040
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/800040 | S() desmethylselegiline and its use in transdermal delivery compositions | Mar 4, 2001 | Issued |
Array
(
[id] => 1448966
[patent_doc_number] => 06455060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-09-24
[patent_title] => 'S() desmethylselegiline and its use to treat immune system dysfunction'
[patent_app_type] => B2
[patent_app_number] => 09/800022
[patent_app_country] => US
[patent_app_date] => 2001-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 12784
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455060.pdf
[firstpage_image] =>[orig_patent_app_number] => 09800022
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/800022 | S() desmethylselegiline and its use to treat immune system dysfunction | Mar 4, 2001 | Issued |
Array
(
[id] => 6572981
[patent_doc_number] => 20020165505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Pervaporation separation of volatile siloxanes from emulsions'
[patent_app_type] => new
[patent_app_number] => 09/797296
[patent_app_country] => US
[patent_app_date] => 2001-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5365
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165505.pdf
[firstpage_image] =>[orig_patent_app_number] => 09797296
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/797296 | Pervaporation separation of volatile siloxanes from emulsions | Feb 28, 2001 | Abandoned |
| 09/786839 | Cxcr2 inhibitors and pmn adhesion and t-cell chemotaxis | Feb 28, 2001 | Abandoned |
Array
(
[id] => 6842582
[patent_doc_number] => 20030147929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Cosmetic agent'
[patent_app_type] => new
[patent_app_number] => 10/204346
[patent_app_country] => US
[patent_app_date] => 2002-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11706
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20030147929.pdf
[firstpage_image] =>[orig_patent_app_number] => 10204346
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/204346 | Cosmetic agent | Feb 21, 2001 | Issued |
| 09/700625 | Use of tricyclic antidepressants for local analgesia | Jan 31, 2001 | Abandoned |
Array
(
[id] => 5889084
[patent_doc_number] => 20020013294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives'
[patent_app_type] => new
[patent_app_number] => 09/774558
[patent_app_country] => US
[patent_app_date] => 2001-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13974
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20020013294.pdf
[firstpage_image] =>[orig_patent_app_number] => 09774558
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/774558 | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives | Jan 30, 2001 | Abandoned |
Array
(
[id] => 6893844
[patent_doc_number] => 20010016210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-23
[patent_title] => 'Bioadhesive microspheres and their use as drug delivery and imaging systems'
[patent_app_type] => new
[patent_app_number] => 09/773229
[patent_app_country] => US
[patent_app_date] => 2001-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11921
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20010016210.pdf
[firstpage_image] =>[orig_patent_app_number] => 09773229
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/773229 | Bioadhesive microspheres and their use as drug delivery and imaging systems | Jan 30, 2001 | Issued |
Array
(
[id] => 7041233
[patent_doc_number] => 20010005721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-06-28
[patent_title] => 'Heel crack healing composition and method therefor'
[patent_app_type] => new-utility
[patent_app_number] => 09/772006
[patent_app_country] => US
[patent_app_date] => 2001-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6657
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20010005721.pdf
[firstpage_image] =>[orig_patent_app_number] => 09772006
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/772006 | Heel crack healing composition and method therefor | Jan 28, 2001 | Abandoned |
Array
(
[id] => 1564154
[patent_doc_number] => 06375962
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-04-23
[patent_title] => 'Barrier cream comprising hexamethylenetetramine or derivative thereof'
[patent_app_type] => B2
[patent_app_number] => 09/767136
[patent_app_country] => US
[patent_app_date] => 2001-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 8684
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/375/06375962.pdf
[firstpage_image] =>[orig_patent_app_number] => 09767136
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/767136 | Barrier cream comprising hexamethylenetetramine or derivative thereof | Jan 22, 2001 | Issued |
Array
(
[id] => 5987268
[patent_doc_number] => 20020098994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'One time use disposable paper soap and method of making'
[patent_app_type] => new
[patent_app_number] => 09/769000
[patent_app_country] => US
[patent_app_date] => 2001-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 953
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20020098994.pdf
[firstpage_image] =>[orig_patent_app_number] => 09769000
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/769000 | One time use disposable paper soap and method of making | Jan 21, 2001 | Abandoned |
Array
(
[id] => 8542900
[patent_doc_number] => 08318186
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-27
[patent_title] => 'Use of at least a fatty ester for preparing a composition designed to inhibit 5-α-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive'
[patent_app_type] => utility
[patent_app_number] => 10/181370
[patent_app_country] => US
[patent_app_date] => 2001-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8214
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10181370
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/181370 | Use of at least a fatty ester for preparing a composition designed to inhibit 5-α-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive | Jan 17, 2001 | Issued |
Array
(
[id] => 782490
[patent_doc_number] => 06991781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-31
[patent_title] => 'Delivery of reactive agents via bi-layer structures for use in shelf-stable products'
[patent_app_type] => utility
[patent_app_number] => 09/764560
[patent_app_country] => US
[patent_app_date] => 2001-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10119
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 277
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/991/06991781.pdf
[firstpage_image] =>[orig_patent_app_number] => 09764560
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/764560 | Delivery of reactive agents via bi-layer structures for use in shelf-stable products | Jan 16, 2001 | Issued |
Array
(
[id] => 6885094
[patent_doc_number] => 20010039258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-08
[patent_title] => 'Active agent transport systems'
[patent_app_type] => new
[patent_app_number] => 09/760307
[patent_app_country] => US
[patent_app_date] => 2001-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 20528
[patent_no_of_claims] => 111
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20010039258.pdf
[firstpage_image] =>[orig_patent_app_number] => 09760307
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/760307 | Active agent transport systems | Jan 10, 2001 | Abandoned |
Array
(
[id] => 5845329
[patent_doc_number] => 20020132801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Drospirenone for hormone replacement therapy'
[patent_app_type] => new
[patent_app_number] => 09/757688
[patent_app_country] => US
[patent_app_date] => 2001-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8903
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132801.pdf
[firstpage_image] =>[orig_patent_app_number] => 09757688
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/757688 | Drospirenone for hormone replacement therapy | Jan 10, 2001 | Abandoned |
Array
(
[id] => 1415476
[patent_doc_number] => 06506390
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-01-14
[patent_title] => 'Progestogen-anti-progestogen regimens'
[patent_app_type] => B2
[patent_app_number] => 09/757048
[patent_app_country] => US
[patent_app_date] => 2001-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2490
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/506/06506390.pdf
[firstpage_image] =>[orig_patent_app_number] => 09757048
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/757048 | Progestogen-anti-progestogen regimens | Jan 7, 2001 | Issued |
Array
(
[id] => 6889203
[patent_doc_number] => 20010024658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-27
[patent_title] => 'Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin'
[patent_app_type] => new
[patent_app_number] => 09/751968
[patent_app_country] => US
[patent_app_date] => 2000-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16582
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20010024658.pdf
[firstpage_image] =>[orig_patent_app_number] => 09751968
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/751968 | Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin | Dec 28, 2000 | Issued |
Array
(
[id] => 5858586
[patent_doc_number] => 20020122823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Soft tablet containing dextrose monohydrate'
[patent_app_type] => new
[patent_app_number] => 09/752899
[patent_app_country] => US
[patent_app_date] => 2000-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2393
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20020122823.pdf
[firstpage_image] =>[orig_patent_app_number] => 09752899
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/752899 | Soft tablet containing dextrose monohydrate | Dec 28, 2000 | Abandoned |
Array
(
[id] => 1580056
[patent_doc_number] => 06423321
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-23
[patent_title] => 'Cytokine antagonists for the treatment of sensorineural hearing loss'
[patent_app_type] => B1
[patent_app_number] => 09/749189
[patent_app_country] => US
[patent_app_date] => 2000-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5379
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/423/06423321.pdf
[firstpage_image] =>[orig_patent_app_number] => 09749189
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/749189 | Cytokine antagonists for the treatment of sensorineural hearing loss | Dec 26, 2000 | Issued |